Brand-name drugs more likely with Part D

06/10/2013 | Reuters · MedPage Today (free registration)

A study found that beneficiaries of Medicare Part D are up to three times more likely to be prescribed brand-name diabetes treatments instead of generics compared with patients covered by the Department of Veterans Affairs. Researchers estimated that greater use of generics could have lowered Medicare costs by $1.4 billion in 2008. "It represents essentially spending that is probably not necessary for most people," said lead researcher Dr. Walid Gellad of the Veterans Affairs Pittsburgh Healthcare System.

View Full Article in:

Reuters · MedPage Today (free registration)